Recombinant multi-species OXT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OXT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a precursor protein that is processed to produce oxytocin and neurophysin I. Oxytocin is a posterior pituitary hormone which is synthesized as an inactive precursor in the hypothalamus along with its carrier protein neurophysin I. Together with neurophysin, it is packaged into neurosecretory vesicles and transported axonally to the nerve endings in the neurohypophysis, where it is either stored or secreted into the bloodstream. The precursor seems to be activated while it is being transported along the axon to the posterior pituitary. This hormone contracts smooth muscle during parturition and lactation. It is also involved in cognition, tolerance, adaptation and complex sexual and maternal behaviour, as well as in the regulation of water excretion and cardiovascular functions. [provided by RefSeq, Dec 2013]
The Alternative Names of target: OT,OT-NPI,OTNPI,OXT,OXT-NPI,Oxt,Oxy,Oxytocin-neurophysin 1

Target products collectionGo to OXT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1165-Ag-1/ GM-Tg-hg-SE1165-Ag-2 Human OXT protein Human
GM-Tg-rg-SE1165-Ag-1/ GM-Tg-rg-SE1165-Ag-2 Rat OXT protein Rat
GM-Tg-mg-SE1165-Ag-1/ GM-Tg-mg-SE1165-Ag-2 Mouse OXT protein Mouse
GM-Tg-cynog-SE1165-Ag-1/ GM-Tg-cynog-SE1165-Ag-2 Cynomolgus/Rhesus macaque OXT protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1165-Ag-1/ GM-Tg-felg-SE1165-Ag-2 Feline OXT protein Feline
GM-Tg-cang-SE1165-Ag-1/ GM-Tg-cang-SE1165-Ag-2 Canine OXT protein Canine
GM-Tg-bovg-SE1165-Ag-1/ GM-Tg-bovg-SE1165-Ag-2 Bovine OXT protein Bovine
GM-Tg-equg-SE1165-Ag-1/ GM-Tg-equg-SE1165-Ag-2 Equine OXT protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1165-Ag-1/ GM-Tg-hg-SE1165-Ag-2; GM-Tg-rg-SE1165-Ag-1/ GM-Tg-rg-SE1165-Ag-2;
GM-Tg-mg-SE1165-Ag-1/ GM-Tg-mg-SE1165-Ag-2; GM-Tg-cynog-SE1165-Ag-1/ GM-Tg-cynog-SE1165-Ag-2;
GM-Tg-felg-SE1165-Ag-1/ GM-Tg-felg-SE1165-Ag-2; GM-Tg-cang-SE1165-Ag-1/ GM-Tg-cang-SE1165-Ag-2;
GM-Tg-bovg-SE1165-Ag-1/ GM-Tg-bovg-SE1165-Ag-2; GM-Tg-equg-SE1165-Ag-1/ GM-Tg-equg-SE1165-Ag-2
Products Name OXT protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name OXT
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OXT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.